The link between genetic polymorphism of glutathione-S-transferases, GSTM1, and GSTT1 and diffuse large B-cell lymphoma in Egypt

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 8, 2012, Pages 1363-1368

  Abdel Rahman, Hala A ^a   Khorshied, Mervat M ^a   Elazzamy, Haidy H ^a   Khorshid, Ola M ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

DLBCL; Egypt; Genetic susceptibility; GSTM1; GSTT1

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; EGYPT; EGYPTIAN; ETHNIC GROUP; FEMALE; GENE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUTATHIONE TRANSFERASE M1 GENE; GLUTATHIONE TRANSFERASE T1 GENE; HUMAN; HUMAN TISSUE; INHERITANCE; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLEX POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CHEMORADIOTHERAPY; EGYPT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; YOUNG ADULT;

EID: 84864352825     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1208-0     Document Type: Article

References (28)

1. Abdelhamid T, Samra M, Ramadan H, Mehessin M, Mokhtar N (2011) Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study. J Natl Cancer Inst 23:17-24
2. Abdou AG, Asaad NY, Abd El-Wahed MM, et al. (2011) The Prognostic Value of Skp2 Expression in Egyptian Diffuse Large B-Cell Lymphoma. Appl Immunohistochem Mol Morphol (Epub ahead of print)
3. Al Dayel F, Al-Rasheed M, Ibrahim M et al (2008) Polymorphisms of drug-metabolizing enzymes CYP1A1, GSTT and GSTP contribute to the development of diffuse large B-cell lymphoma risk in the Saudi Arabian population. Leuk Lymphoma 49(1):122-129 (Pubitemid 351146891)
4. Bajpai P, Agwrawal D, Tripathi AK (2007) Genetic polymorphism of GSTM1 and T1 and risk to chronic myeloid leukemia. Leuk Res 31(10):1359-1363
5. Chiu BC, Kolar C, Gapstur SM et al (2005) Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma. R J Haematol 128:610-615
6. Cho HJ, Eom H, Kim H et al (2010) Glutathione-S-transferase genotypes influence the risk of chemotherapy-related toxicities and prognosis in Korean patients with diffuse large B-cell lymphoma. Cancer Genet Cytogenet 198:40-46
7. Coughlin SS, Hall IJ (2002) A review of genetic polymorphisms and prostate cancer risk. Ann Epidemiol 12(3):182-196 (Pubitemid 34189720)
8. De Roose AJ, Gold IS, Wang S et al (2006) Metabolic gene variants and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 15:1647-1653 (Pubitemid 44497100)
9. Goldman L, Ezzat S, Mokhtar N et al (2009a) Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypes. Cancer Causes Control 20(6):981-987
10. Goldman L, Ezzat S, Mokhtar N et al (2009b) Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypes. Cancer Causes Control 20(6):981-998
11. Gra OA, Glotov AS, Kozhekbaeva Zh et al (2002) Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia. Mol Biol (Mosk) 42(2):214-225
12. Gra OA, Glotov AS, Nikitin EA et al (2008) Polymorphisms in xenobiotic metabolizing enzymes genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphomas in adult Russian patients. Am J Hematol 83(4):279-287 (Pubitemid 351458005)
13. Han X, Li Y, Huang J et al (2010) Identification of predictive pathways for non-hodgkin lymphoma prognosis. Cancer Inf 9:281-292
14. Harris N, Stein H, Coupland S et al (2001) New approaches to lymphoma diagnosis. Am Soc Haematol 1(1):194-220
15. Ibrahim AM, Abdel Rahman HA, Khorshied MM, Sami R, Nasr NM, Khorshid OM (2011) Tumor necrosis factor alpha! 308 and Lymphotoxin alpha+ 252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt. Leuk Res [Epub ahead of print]
16. Kelemen LE, Cerhan JR, Lim U, Davis S, Cozen W et al (2006) Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute-surveillance, epidemiology, and end results population-based casecontrol study. Am J Clin Nutr 83:1401-1410 (Pubitemid 44713073)
17. Kerridge I, Lincz L, Scorgie F et al (2002) Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk. Br J Haematol 118:477-481 (Pubitemid 34994652)
18. McIlwain CC, Townsend DM, Tew KD (2006) Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25(11):1639-1648
19. Meyer A (1996) Overview of enzymes of drug metabolism. J Pharmakokinet Pharmacodynam 24:449-459
20. Moyer AM, Salavaggione OE, Hebbrind SJ et al (2007) Glutathione S-transferase T1 and M1: gene sequence variation and functional genomics. Clin Cancer Res 13(23):2207-2216
21. Oken M, Creech R, Tormey D, Horton J, Davis T et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655 (Pubitemid 13149996)
22. Omiecinski CJ, Vanden Heuvel JP, Perdew GH, Peters JM (2011) Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. Toxicol Sci 120(S1):S49-S75
23. Park SK, Yoo KY, Lee SJ et al (2000) Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Pharmacogenetics 10:301-309
24. Sarmanova J, Benesova K, Gut I et al (2001) Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Hum Mol Genet 10:1265-1273 (Pubitemid 32600480)
25. Sheehan D, Meare G, Foley VM et al (2001) Structure, function and evolution of glutathione transferases: implication for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J 360:1-16 (Pubitemid 33081943)
26. Skibola CF, Curry JD, Nieters A (2007) Genetic susceptibility to lymphoma. Haematologica 92:960-969 (Pubitemid 350144243)
27. Soucek P, Sarmanova J, Nedelcheva-Kristensen V et al (2002) Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Int Arch Occup Environ Health 75(1):86-92
28. Vogl FD, Taioli E, Maugard C, Zheng W, Pinto LF, Ambrosone C, Parl FF, Nedelcheva-Kristensen V, Rebbeck TR, Brennan P, Boffetta P (2004) Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev 13(9):1473-1479 (Pubitemid 39202314)